Novo CEO pressed by Senate to cut charges of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the organization would look at new talks with insurers with regards to the listing rates of Wegovy and copyright when they pledge to keep the medicines on their formularies. Elevance https://kethek.com/